Demand for Remdesivir is not expected to reduce in India, even after interim results of the World Health Organization’s (WHO) Solidarity Trial have shown the drug is not effective in reducing mortality among Covid-19 patients.from Industry-Economic Times
Read The Rest:economictimes...
